PALISADE BIO, INC. — Director's Dealing 2015

Jul 6, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Neuralstem, Inc. (CUR)
CIK: 0001357459
Period of Report: 2015-07-01

Reporting Person: OLDAKER WILLIAM CLYDE (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-07-01	Common Stock	A	53476	$0.00	Acquired	181826	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-07-01	Common Stock Purchase Option	$1.87	A	99824	Acquired	2022-07-01	Common Stock (99824)	Direct

Footnotes

F1: The shares represented are restricted stock grants pursuant to compensatory Annual Grant for director services. The shares vest quarterly on 9/30/15, 12/31/15, 3/31/15 and 6/30/15.

F2: Represents compensatory Annual Grant for director services. The options vest quarterly on 9/30/15, 12/31/15, 3/31/15 and 6/30/15.